PBM Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for PBM Pharmaceuticals

Access the complete profile.

PBM Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	200 Garrett Street Suite P Charlottesville, VA 22902

Note: Revenues for privately held companies are statistical evaluations.


PBM Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • PBM Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • PBM Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

PBM Pharmaceuticals Annual Revenue and Growth Rate

PBM Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: PBM Pharmaceuticals's revenues are gauged from an analysis of company filings.

PBM Pharmaceuticals's Income Statement (based on Industry Averages)

PBM Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that PBM Pharmaceuticals is developing and marketing. PBM Pharmaceuticals doesn't have any recent trademark applications, indicating PBM Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
REVIVE PHARMACEUTICALS Central nervous system depressant especially useful as an antinauseant and sedative and folic acid supplements	11/08/2013
ALLADRYL pharmaceutical preparations including for allergies and to relieve itching	03/12/2013
DONNAGEL pharmaceutical preparations, namely, anti-diarrheal preparations	01/24/2013

See all trademarks and details in the Full Report.

Market Share of PBM Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as PBM Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to PBM Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PBM PHARMACEUTICALS	Charlottesville, VA	100
GENERAL ATOMICS COMMONWEALTH COMPUTER RESEARCH	Charlottesville, VA	93
VIRGINIA DIODES	Charlottesville, VA	79
LUNA LABS USA	Charlottesville, VA	59
PBM CAPITAL GROUP	Charlottesville, VA	57
ATLANTIC RESEARCH GROUP	Charlottesville, VA	54

Future Competition: PBM Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as PBM Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)